Our IPR is locked & loaded, maybe just maybe your hunch is spot on, the BOD have probably got several options open to them. 3 or 4 RNS'S due this month, heres hoping for an early xmas gift
Good morning SOG, thankyou for your latest thoughts, we remain intrigued as to how things will pan out. A question. Given that 1801 is likely to be of benefit to a range of auto immune disorders, how does any on licence trial programme develop ? For instance if the favoured indication is sepsis for example can Sar at the same time side by side trial say lupus with a n other pharma ? As has been suggested many times previously there are multiple immune disorders out there and it would be great if we were trialling our molecule against numerous diseases concurrently ! Obviously cost is a huge factor.
Agree Afham, my hope is that the indication is sepsis, massive market and on a personal level my mum only just survived it recently. So many conditions to target however, nice position to be in ! Keep calm and buy more if you can.
That made me chuckle. Im aiming to get into the good beer guide with my new micro brewery, or better still visit SOG's , he seems to know a thing or 2 about the amber nectar !
Great reading the last few days chaps, oh to be a fly on the wall at the board meetings over the last few weeks/months. Still calmly sat with my golden tickets patiently awaiting some news. Its coming our way without a doubt GLA
Attempted to read through your link and my brain began to smoke ! Thats way beyond me, however i get the general message, as has been said before if we get a therapy to improve patients with sepsis then £1 per share would be surpassed many times over. Have a great weekend all.
Very well put , human nature usually errs towards the impatient and its hard sometimes with this share. Im taking the advice of a few learned LTH'S here and ignoring the short term ups & downs, just occasionally i look in on the BB for a read. Off for a long stroll, keep calm, keep the faith and GLA